UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 26, 2021 10:00 A.M.
Form:
S-3
CIK:
0001411685
Company Name:
VistaGen Therapeutics, Inc.
File Number:
333-254299